| CARDIOLOGY UPDATE |
|
| Year : 2015 | Volume
: 1
| Issue : 2 | Page : 206-211 |
|
|
Heart failure report
Pamila Dua1, Himanshu Meghwani B. K. S Sastry2
1 Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India
2 Department of Cardiology, Care Hospitals, Hyderabad, Telangana, India
Correspondence Address:
Dr. Himanshu Meghwani B. K. S Sastry
Care Hospitals, Hyderabad, Telangana
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2395-5414.166343
|
|
|
Despite advancements in diagnosis and pharmacotherapy, heart failure (HF) remains as a major health problem. The prevalence in the general population is estimated to range from 0.3% to 2.0%, increases considerably with age, and approximately doubles with every additional decade of life. In the last two decades, hospital admission rates for HF have increased steadily. The prevalence of HF can be estimated at 1–2% in the Western world and the incidence approaches 5–10/1000 persons/year. Estimates of the occurrence of HF in the developing world are largely absent. In a recent US population-based study, the prevalence of HF was 2.2% (95 confidence interval 1.6–2.8%), increasing from 0.7% in persons aged 45 through 54 years to 8.4% for those aged 75 years or older. In this article, we look at the major papers published in HF in the past 1 year. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
